It obvious that use of expired medicines where there are alternatives is unacceptable. There are, however, situations where the only available alternative medical product (medicine) used for life-threatening disease condition is expired and left with bare hands. What do healthcare professionals do on this situation, especially in this covid-19 pandemic where procurement is a challenge? Based on the risks-benefits assessment - the risk of leaving a patient without alternative and using expired medicine to save the patient and its associated risks - if they clinicians are going to use the product, what strategies they should follow to avoid medico-legal issues and transparency with consumers.
Looking forward to hear back from you?
Kind regards,
Mulugeta